Banque Transatlantique SA Sells 53,861 Shares of Danaher Corporation $DHR

Banque Transatlantique SA trimmed its stake in shares of Danaher Corporation (NYSE:DHR) by 23.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 173,803 shares of the conglomerate’s stock after selling 53,861 shares during the quarter. Danaher comprises about 1.0% of Banque Transatlantique SA’s portfolio, making the stock its 21st biggest holding. Banque Transatlantique SA’s holdings in Danaher were worth $39,868,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. JPL Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter worth approximately $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the third quarter valued at approximately $27,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher during the fourth quarter worth $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $177.74 on Friday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The business has a 50-day simple moving average of $179.99 and a two-hundred day simple moving average of $203.25. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock has a market cap of $125.80 billion, a PE ratio of 34.38, a PEG ratio of 2.27 and a beta of 0.81.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period last year, the firm posted $1.88 earnings per share. Analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on DHR shares. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. JPMorgan Chase & Co. dropped their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Evercore lifted their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Piper Sandler assumed coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. Finally, Guggenheim dropped their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.